Dr Alina C Justiz, MD | |
1215 Crossroads Blvd Ste 100, Norman, OK 73072-3334 | |
(405) 606-8920 | |
(405) 310-6720 |
Full Name | Dr Alina C Justiz |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 23 Years |
Location | 1215 Crossroads Blvd Ste 100, Norman, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053405951 | NPI | - | NPPES |
147562101 | Medicaid | TX | |
8M0722 | Other | TX | BC/BS |
147562100 | Other | TX | FIRSTCARE COMMERCIAL |
200072520A | Medicaid | OK | |
8M0736 | Other | TX | HMO BLUE |
200495300A | Medicaid | OK | |
202003982 | Medicaid | NM | |
179159201 | Medicaid | TX | |
202003982 | Other | NM | PRESBYTERIAN COMMERCIAL |
50407881 | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | M2358 (Texas) | Secondary |
207L00000X | Anesthesiology | 27481 (Oklahoma) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oklahoma Pain Physicians Pc | 1658506290 | 7 |
News Archive
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
A new video article in JoVE, the Journal of Visualized Experiments, describes a novel procedure to monitor brain function and aid in functional mapping of patients with diseases such as epilepsy. This procedure illustrates the use of pre-placed electrodes for cortical mapping in the brains of patients who are undergoing surgery to minimize the frequency of seizures. This technique, while invasive, provides real-time analysis of brain function at a much higher resolution than current technologies.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
› Verified 1 days ago
Entity Name | Oklahoma Pain Physicians Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649518564 PECOS PAC ID: 1658506290 Enrollment ID: O20131106001426 |
News Archive
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
A new video article in JoVE, the Journal of Visualized Experiments, describes a novel procedure to monitor brain function and aid in functional mapping of patients with diseases such as epilepsy. This procedure illustrates the use of pre-placed electrodes for cortical mapping in the brains of patients who are undergoing surgery to minimize the frequency of seizures. This technique, while invasive, provides real-time analysis of brain function at a much higher resolution than current technologies.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
› Verified 1 days ago
Entity Name | Integrated Medical Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487837456 PECOS PAC ID: 4587886593 Enrollment ID: O20141106001718 |
News Archive
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
A new video article in JoVE, the Journal of Visualized Experiments, describes a novel procedure to monitor brain function and aid in functional mapping of patients with diseases such as epilepsy. This procedure illustrates the use of pre-placed electrodes for cortical mapping in the brains of patients who are undergoing surgery to minimize the frequency of seizures. This technique, while invasive, provides real-time analysis of brain function at a much higher resolution than current technologies.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alina C Justiz, MD 1215 Crossroads Blvd Ste 100, Norman, OK 73072-3334 Ph: (405) 606-8920 | Dr Alina C Justiz, MD 1215 Crossroads Blvd Ste 100, Norman, OK 73072-3334 Ph: (405) 606-8920 |
News Archive
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
A new video article in JoVE, the Journal of Visualized Experiments, describes a novel procedure to monitor brain function and aid in functional mapping of patients with diseases such as epilepsy. This procedure illustrates the use of pre-placed electrodes for cortical mapping in the brains of patients who are undergoing surgery to minimize the frequency of seizures. This technique, while invasive, provides real-time analysis of brain function at a much higher resolution than current technologies.
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
› Verified 1 days ago
Quentin Lobb, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3650 W Rock Creek Rd, Suiet 100, Norman, OK 73072 Phone: 405-701-3418 Fax: 405-701-3451 | |
Shane Edward Stidham, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3650 W Rock Creek Rd, Suite 100, Norman, OK 73072 Phone: 405-701-3418 Fax: 405-701-3451 | |
John Billy Hill, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3650 W Rock Creek Rd, Suite 100, Norman, OK 73072 Phone: 405-701-3418 Fax: 405-701-3451 | |
Jason Edward Leonard, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3650 W Rock Creek Rd, Suite 100, Norman, OK 73072 Phone: 405-701-3418 Fax: 405-701-3451 | |
Braden Riehl Cross, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 805 E Robinson St, Norman, OK 73071 Phone: 405-360-7576 Fax: 405-360-7762 | |
Anderson F Greenhaw, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |